Search Results - "Atorrasagasti, Catalina"

Refine Results
  1. 1

    The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease by Atorrasagasti, Catalina, Onorato, Agostina M., Mazzolini, Guillermo

    Published in Journal of physiology and biochemistry (01-11-2023)
    “…Secreted protein acidic and rich in cysteine (SPARC) is an extracellular matrix glycoprotein with pleiotropic functions, which is expressed in adipose,…”
    Get full text
    Journal Article
  2. 2

    A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets by Bayo, Juan, Fiore, Esteban J., Dominguez, Luciana M., Real, Alejandrina, Malvicini, Mariana, Rizzo, Manglio, Atorrasagasti, Catalina, García, Mariana G., Argemi, Josepmaria, Martinez, Elisabeth D., Mazzolini, Guillermo D.

    Published in Journal of hepatology (01-07-2019)
    “…[Display omitted] •Mutations and expression alterations of epigenetic modifiers are frequent in HCC.•Jumonji lysine demethylase inhibitors normalize aggressive…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence by Mazzolini, Guillermo, Sowa, Jan-Peter, Atorrasagasti, Catalina, Kücükoglu, Özlem, Syn, Wing-Kin, Canbay, Ali

    Published in Cells (Basel, Switzerland) (11-11-2020)
    “…Non-alcoholic fatty liver disease (NAFLD) is defined clinicopathologically by the accumulation of lipids in >5% of hepatocytes and the exclusion of secondary…”
    Get full text
    Journal Article
  6. 6

    SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease by Mazzolini, Guillermo, Atorrasagasti, Catalina, Onorato, Agostina, Peixoto, Estanislao, Schlattjan, Martin, Sowa, Jan-Peter, Sydor, Svenja, Gerken, Guido, Canbay, Ali

    Published in Scientific reports (15-01-2018)
    “…Mechanisms that control progression from simple steatosis to steato-hepatitis and fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) are…”
    Get full text
    Journal Article
  7. 7

    Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling by Amin, Guadalupe, Castañeda, Sheila Lucía, Zabalegui, Federico, Belli, Carolina, Atorrasagasti, Catalina, Miriuka, Santiago Gabriel, Moro, Lucía Natalia

    Published in Stem cell research (01-09-2023)
    “…The arrhythmogenic cardiomyopathy (ACM) is an inherited heart muscle disease characterized by the progressive replacement of contractile myocardium by…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis by Piccioni, Flavia, Fiore, Esteban, Bayo, Juan, Atorrasagasti, Catalina, Peixoto, Estanislao, Rizzo, Manglio, Malvicini, Mariana, Tirado-González, Irene, García, Mariana G, Alaniz, Laura, Mazzolini, Guillermo

    Published in Glycobiology (Oxford) (01-08-2015)
    “…Cirrhosis is characterized by an excessive accumulation of extracellular matrix components including hyaluronic acid (HA) and is widely considered a…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells by Fiore, Esteban, Malvicini, Mariana, Bayo, Juan, Peixoto, Estanislao, Atorrasagasti, Catalina, Sierra, Romina, Rodríguez, Marcelo, Gómez Bustillo, Sofia, García, Mariana G, Aquino, Jorge B, Mazzolini, Guillermo

    Published in Stem cell research & therapy (22-11-2016)
    “…Cirrhosis is a major health problem worldwide and new therapies are needed. Hepatic macrophages (hMø) have a pivotal role in liver fibrosis, being able to act…”
    Get full text
    Journal Article
  16. 16

    Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells by Atorrasagasti, Catalina, Malvicini, Mariana, Aquino, Jorge B., Alaniz, Laura, Garcia, Mariana, Bolontrade, Marcela, Rizzo, Manglio, Podhajcer, Osvaldo L., Mazzolini, Guillermo

    Published in International journal of cancer (01-06-2010)
    “…Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer‐related death worldwide. Current treatments are extremely…”
    Get full text
    Journal Article
  17. 17

    A Novel Synergistic Combination of Cyclophosphamide and Gene Transfer of Interleukin-12 Eradicates Colorectal Carcinoma in Mice by MALVICINI, Mariana, RIZZO, Miguel, MAZZOLINI, Guillermo, ALANIZ, Laura, PINERO, Federico, GARCIA, Mariana, ATORRASAGASTI, Catalina, AQUINO, Jorge B, ROZADOS, Viviana, GRACIELA SCHAROVSKY, O, MATAR, Pablo

    Published in Clinical cancer research (01-12-2009)
    “…Purpose: Interleukin-12 (IL-12) is an immunostimulatory cytokine with potent antitumor effects in several animal models. However, serious toxicity has been…”
    Get full text
    Journal Article
  18. 18

    Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats by Camino, Alejandra M., Atorrasagasti, Catalina, Maccio, Daniela, Prada, Federico, Salvatierra, Edgardo, Rizzo, Miguel, Alaniz, Laura, Aquino, Jorge B., Podhajcer, Osvaldo. L., Silva, Marcelo, Mazzolini, Guillermo

    Published in The journal of gene medicine (01-09-2008)
    “…Background The interaction between fibrogenic cells and extracellular matrix plays a role in liver fibrosis, yet the mechanisms are largely unknown. Secreted…”
    Get full text
    Journal Article
  19. 19

    Immunotherapy and immunoescape in colorectal cancer by Mazzolini, Guillermo, Murillo, Oihana, Atorrasagasti, Catalina, Dubrot, Juan, Tirapu, Iñigo, Rizzo, Miguel, Arina, Ainhoa, Alfaro, Carlos, Azpilicueta, Arantza, Berasain, Carmen, Perez-Gracia, José L, Gonzalez, Alvaro, Melero, Ignacio

    Published in World journal of gastroenterology : WJG (28-11-2007)
    “…Immunotherapy encompasses a variety of interventions and techniques with the common goal of eliciting tumor cell destructive immune responses. Colorectal…”
    Get full text
    Journal Article
  20. 20